title: Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue.
authors.forename: R
authors.initials: R
authors.lastname: Nabbi
authors.forename: M L
authors.initials: ML
authors.lastname: Riess
authors.forename: H J
authors.initials: HJ
authors.lastname: Woehlck
mesh_terms: D000368:Aged; D057911:Angiotensin Receptor Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D015283:Citalopram / Q000627:therapeutic use; D000077324:Crystalloid Solutions; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004351:Drug Resistance; D005260:Female; D015390:Gastric Bypass; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000188:drug therapy*; D007552:Isotonic Solutions; D009767:Obesity, Morbid / Q000150:complications / Q000601:surgery; D010656:Phenylephrine / Q000494:pharmacology / Q000627:therapeutic use; D011300:Preoperative Care; D011412:Propanolamines / Q000627:therapeutic use; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014633:Valine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D057911:Angiotensin Receptor Antagonists; D002227:Carbazoles; D000077324:Crystalloid Solutions; D007552:Isotonic Solutions; D011412:Propanolamines; D013777:Tetrazoles; D015283:Citalopram; D000077261:Carvedilol; D010656:Phenylephrine; D000068756:Valsartan; D014633:Valine